CN110498847A - Preparation and crystallization method of rice receptor protein RGA5A_S - Google Patents
Preparation and crystallization method of rice receptor protein RGA5A_S Download PDFInfo
- Publication number
- CN110498847A CN110498847A CN201810475252.8A CN201810475252A CN110498847A CN 110498847 A CN110498847 A CN 110498847A CN 201810475252 A CN201810475252 A CN 201810475252A CN 110498847 A CN110498847 A CN 110498847A
- Authority
- CN
- China
- Prior art keywords
- protein
- rga5a
- rice
- receptor protein
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 49
- 235000009566 rice Nutrition 0.000 title claims abstract description 47
- 108020003175 receptors Proteins 0.000 title claims abstract description 27
- 102000005962 receptors Human genes 0.000 title claims abstract description 27
- 238000002425 crystallisation Methods 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 240000007594 Oryza sativa Species 0.000 title description 3
- 241000209094 Oryza Species 0.000 claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 45
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 24
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- 239000006228 supernatant Substances 0.000 claims abstract description 12
- 238000001042 affinity chromatography Methods 0.000 claims abstract description 11
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 11
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 claims abstract description 10
- 239000002808 molecular sieve Substances 0.000 claims abstract description 6
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 230000009465 prokaryotic expression Effects 0.000 claims abstract description 3
- 230000006037 cell lysis Effects 0.000 claims abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 27
- 239000013078 crystal Substances 0.000 claims description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 10
- 239000000872 buffer Substances 0.000 claims description 9
- 239000012149 elution buffer Substances 0.000 claims description 9
- 239000013604 expression vector Substances 0.000 claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 239000013592 cell lysate Substances 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000012139 lysis buffer Substances 0.000 claims description 4
- 239000012460 protein solution Substances 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 230000014509 gene expression Effects 0.000 claims description 3
- 239000006166 lysate Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 230000002934 lysing effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 2
- 241000588722 Escherichia Species 0.000 claims 1
- 238000005336 cracking Methods 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 239000011592 zinc chloride Substances 0.000 claims 1
- 235000005074 zinc chloride Nutrition 0.000 claims 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims 1
- 230000008025 crystallization Effects 0.000 abstract description 6
- 229910021645 metal ion Inorganic materials 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 241001330975 Magnaporthe oryzae Species 0.000 description 6
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 101150035080 RGA5 gene Proteins 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 108700026215 vpr Genes Proteins 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 241000880493 Leptailurus serval Species 0.000 description 3
- 241001344131 Magnaporthe grisea Species 0.000 description 3
- 101150095476 RGA4 gene Proteins 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000004153 renaturation Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000002447 crystallographic data Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000021393 food security Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000009456 molecular mechanism Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- RFXXUWGNVRJTNQ-QXEWZRGKSA-N Arg-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N RFXXUWGNVRJTNQ-QXEWZRGKSA-N 0.000 description 1
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- DQGIAOGALAQBGK-BWBBJGPYSA-N Cys-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N)O DQGIAOGALAQBGK-BWBBJGPYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 244000140063 Eragrostis abyssinica Species 0.000 description 1
- 235000014966 Eragrostis abyssinica Nutrition 0.000 description 1
- 101000658547 Escherichia coli (strain K12) Type I restriction enzyme EcoKI endonuclease subunit Proteins 0.000 description 1
- 101000658543 Escherichia coli Type I restriction enzyme EcoAI endonuclease subunit Proteins 0.000 description 1
- 101000658546 Escherichia coli Type I restriction enzyme EcoEI endonuclease subunit Proteins 0.000 description 1
- 101000658530 Escherichia coli Type I restriction enzyme EcoR124II endonuclease subunit Proteins 0.000 description 1
- 101000658540 Escherichia coli Type I restriction enzyme EcoprrI endonuclease subunit Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 1
- QITBQGJOXQYMOA-ZETCQYMHSA-N Gly-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QITBQGJOXQYMOA-ZETCQYMHSA-N 0.000 description 1
- 101000658545 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Type I restriction enyme HindI endonuclease subunit Proteins 0.000 description 1
- OWYIDJCNRWRSJY-QTKMDUPCSA-N His-Pro-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O OWYIDJCNRWRSJY-QTKMDUPCSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UKTUOMWSJPXODT-GUDRVLHUSA-N Ile-Asn-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N UKTUOMWSJPXODT-GUDRVLHUSA-N 0.000 description 1
- IMRKCLXPYOIHIF-ZPFDUUQYSA-N Ile-Met-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N IMRKCLXPYOIHIF-ZPFDUUQYSA-N 0.000 description 1
- YBKKLDBBPFIXBQ-MBLNEYKQSA-N Ile-Thr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O)N YBKKLDBBPFIXBQ-MBLNEYKQSA-N 0.000 description 1
- KZZCOWMDDXDKSS-CIUDSAMLSA-N Leu-Ser-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KZZCOWMDDXDKSS-CIUDSAMLSA-N 0.000 description 1
- WQWZXKWOEVSGQM-DCAQKATOSA-N Lys-Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN WQWZXKWOEVSGQM-DCAQKATOSA-N 0.000 description 1
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 1
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 1
- HLQWFLJOJRFXHO-CIUDSAMLSA-N Met-Glu-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O HLQWFLJOJRFXHO-CIUDSAMLSA-N 0.000 description 1
- 101000658548 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaIXP endonuclease subunit Proteins 0.000 description 1
- 101000658542 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaVIIIP endonuclease subunit Proteins 0.000 description 1
- 101000658529 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaVIIP endonuclease subunit Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- SZZBUDVXWZZPDH-BQBZGAKWSA-N Pro-Cys-Gly Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1 SZZBUDVXWZZPDH-BQBZGAKWSA-N 0.000 description 1
- AWQGDZBKQTYNMN-IHRRRGAJSA-N Pro-Phe-Asp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(=O)O)C(=O)O AWQGDZBKQTYNMN-IHRRRGAJSA-N 0.000 description 1
- 101150090155 R gene Proteins 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 1
- 101001042773 Staphylococcus aureus (strain COL) Type I restriction enzyme SauCOLORF180P endonuclease subunit Proteins 0.000 description 1
- 101000838760 Staphylococcus aureus (strain MRSA252) Type I restriction enzyme SauMRSORF196P endonuclease subunit Proteins 0.000 description 1
- 101000838761 Staphylococcus aureus (strain MSSA476) Type I restriction enzyme SauMSSORF170P endonuclease subunit Proteins 0.000 description 1
- 101000838758 Staphylococcus aureus (strain MW2) Type I restriction enzyme SauMW2ORF169P endonuclease subunit Proteins 0.000 description 1
- 101001042566 Staphylococcus aureus (strain Mu50 / ATCC 700699) Type I restriction enzyme SauMu50ORF195P endonuclease subunit Proteins 0.000 description 1
- 101000838763 Staphylococcus aureus (strain N315) Type I restriction enzyme SauN315I endonuclease subunit Proteins 0.000 description 1
- 101000838759 Staphylococcus epidermidis (strain ATCC 35984 / RP62A) Type I restriction enzyme SepRPIP endonuclease subunit Proteins 0.000 description 1
- 101000838756 Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) Type I restriction enzyme SsaAORF53P endonuclease subunit Proteins 0.000 description 1
- VYEHBMMAJFVTOI-JHEQGTHGSA-N Thr-Gly-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O VYEHBMMAJFVTOI-JHEQGTHGSA-N 0.000 description 1
- UUSQVWOVUYMLJA-PPCPHDFISA-N Thr-Lys-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UUSQVWOVUYMLJA-PPCPHDFISA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- AYHSJESDFKREAR-KKUMJFAQSA-N Tyr-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AYHSJESDFKREAR-KKUMJFAQSA-N 0.000 description 1
- ZOBLBMGJKVJVEV-BZSNNMDCSA-N Tyr-Lys-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O ZOBLBMGJKVJVEV-BZSNNMDCSA-N 0.000 description 1
- VXFXIBCCVLJCJT-JYJNAYRXSA-N Tyr-Pro-Pro Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O VXFXIBCCVLJCJT-JYJNAYRXSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- YODDULVCGFQRFZ-ZKWXMUAHSA-N Val-Asp-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O YODDULVCGFQRFZ-ZKWXMUAHSA-N 0.000 description 1
- HLBHFAWNMAQGNO-AVGNSLFASA-N Val-His-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCSC)C(=O)O)N HLBHFAWNMAQGNO-AVGNSLFASA-N 0.000 description 1
- NLNCNKIVJPEFBC-DLOVCJGASA-N Val-Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O NLNCNKIVJPEFBC-DLOVCJGASA-N 0.000 description 1
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241000907138 Xanthomonas oryzae pv. oryzae Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004665 defense response Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000012638 fungal effector Substances 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 230000005745 host immune response Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 108091005687 plant receptors Proteins 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Metallurgy (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明公开了水稻受体蛋白RGA5A_S的制备及结晶方法。蛋白RGA5A_S的制备方法为:利用原核表达系统表达水稻受体蛋白RGA5A_S,经过菌体裂解,裂解上清液依次过亲和层析柱、分子筛层析柱,最终得到纯化的目的蛋白;针对蛋白RGA5A_S包含金属离子结构域的特点,在重组菌诱导摇培时,向培养基中添加100μM Zn2+,提高了蛋白稳定性。本发明还提供蛋白RGA5A_S的结晶方法。采用鸟枪法和九宫格法对蛋白结晶条件进行筛选优化,结果蛋白RGA5A_S在0.18‑0.22MNH4NO3和18%‑22%PEG3350条件下,所得晶体大、质量好、分辨率高,该方法重复性好。The invention discloses a preparation and crystallization method of rice receptor protein RGA5A_S. The preparation method of the protein RGA5A_S is as follows: the rice receptor protein RGA5A_S is expressed using a prokaryotic expression system, and after cell lysis, the lysed supernatant is sequentially passed through an affinity chromatography column and a molecular sieve chromatography column to finally obtain a purified target protein; for the protein RGA5A_S It contains the characteristics of metal ion domain, and when the recombinant bacteria are induced to shake culture, 100μM Zn 2+ is added to the medium to improve the protein stability. The invention also provides a method for crystallizing the protein RGA5A_S. Shotgun method and Jiugongge method were used to screen and optimize protein crystallization conditions. As a result, protein RGA5A_S was obtained under the conditions of 0.18-0.22MNH 4 NO 3 and 18%-22% PEG3350. it is good.
Description
技术领域technical field
本发明属于蛋白质结晶领域,具体地说,涉及水稻受体蛋白RGA5A_S的制备及结晶方法。The invention belongs to the field of protein crystallization, and in particular relates to the preparation and crystallization method of rice receptor protein RGA5A_S.
背景技术Background technique
水稻是世界三大经济作物之一,全球超过50%人口的主食(Liu and Wang,2016)。粮食安全成为当今全球经济生产头等大事,人口的持续增长是世界水稻产业发展的原始动力(周锡跃等,2010),至2030年世界水稻至少增长38%才能满足人类的需求(张璟等,2014)。因此,保障水稻稳定的产量与质量,直接关系粮食安全供给和人民温饱等问题,具有非常重要的战略意义。然而,稻谷的安全生产常年受病虫害的危害,其中,Magnaportheoryzae引起的稻瘟病是水稻病虫害中发生最为普遍、危害极大的真菌病害。稻瘟病菌的发生具有“点多面广”、发病面积大、发生区域集中、危害程度严重、区域间发病特点差异大等特点。不仅能够侵染水稻,还能侵染大麦、小麦、画眉草等多种禾本科作物和杂草,导致作物品质的下降。平均每年稻瘟菌引起水稻10%~30%的产量损失,而这足以解决2.12亿~7.42亿人口温饱问题(Fisher et al.,2012)。因此,稻瘟病菌被评为十大病原真菌之首(Dean et al.,2012)。目前,农业生产中主要采用抗病品种和化学杀菌剂对稻瘟病菌进行防控。随着人们生活水平和环保意识提高,越来越注重食物安全和品质,及其绿色环保的生活,化学农药的使用越来越受到限制。因此,选育抗病品种在控制稻瘟病的工作中变得至关重要;而选育抗病品种具有周期长、抗性稳定性差等缺陷。为了满足人们日益增长的粮食需求,迫切需要深入了解水稻受体与稻瘟病菌的协同进化分子机制,为抗病品种选育和品种布局提供科学、合理的理论基础。Rice is one of the three major economic crops in the world and is the staple food of more than 50% of the world's population (Liu and Wang, 2016). Food security has become the top priority in today’s global economic production, and the continuous growth of population is the original driving force for the development of the world’s rice industry (Zhou Xiyue et al., 2010). By 2030, the world’s rice must grow by at least 38% to meet human needs (Zhang Jing et al., 2014) . Therefore, it is of great strategic significance to ensure the stable yield and quality of rice, which is directly related to issues such as food security supply and people's food and clothing. However, the safe production of rice is endangered by pests and diseases all the year round, and rice blast caused by Magnaportheoryzae is the most common and harmful fungal disease among rice pests and diseases. The occurrence of Magnaporthe grisea has the characteristics of "many spots and wide areas", large disease area, concentrated occurrence area, serious damage degree, and large difference in disease characteristics between regions. Not only can it infect rice, but it can also infect a variety of grass crops and weeds such as barley, wheat, and teff, resulting in a decline in crop quality. On average, rice blast fungus causes 10% to 30% yield loss of rice every year, which is enough to solve the problem of food and clothing for 212 million to 742 million people (Fisher et al., 2012). Therefore, Magnaporthe grisea is rated as the top ten pathogenic fungi (Dean et al., 2012). At present, disease-resistant varieties and chemical fungicides are mainly used in agricultural production to prevent and control blast fungus. With the improvement of people's living standards and environmental protection awareness, people pay more and more attention to food safety and quality, and their green life, the use of chemical pesticides is more and more restricted. Therefore, the selection and breeding of disease-resistant varieties has become very important in the work of controlling rice blast; however, the selection and breeding of disease-resistant varieties has defects such as long cycle and poor resistance stability. In order to meet people's increasing food demand, it is urgent to deeply understand the molecular mechanism of co-evolution of rice receptors and blast fungus, so as to provide a scientific and reasonable theoretical basis for disease-resistant variety breeding and variety distribution.
蛋白质是构成细胞的基本有机物,也是生命活动的主要承担者和执行者,解析其分子结构对于了解其功能具有重要意义。结构生物学主要以生物学功能为主线,借助分子生物物理学和生物化学剖析生物大分子及其复合物三维结构,从原子的角度阐释蛋白质、核酸等发挥生物功能的分子机制。因此,深入了解蛋白质三维结构,不仅有利于人们深入了解蛋白质生物学功能,也为水稻抗病品种进行遗传改良和合理布局、药物设计、疫苗研发等应用领域提供理论基础。X-ray晶体学解析蛋白质三维结构是公认的最为可靠的方法。但是该技术一方面对蛋白质纯度(95%~99%)、稳定性、生物活性等有严格的要求;另一方面的瓶颈是结晶方法。因此,获得高质量的蛋白样品和稳定性好、可重复的高质量晶体对推进结构生物学解析蛋白质-蛋白质、蛋白质-核酸等生物大分子互作机制具有重要意义。Protein is the basic organic matter that constitutes cells, and is also the main bearer and executor of life activities. Analyzing its molecular structure is of great significance for understanding its function. Structural biology mainly focuses on biological functions. With the help of molecular biophysics and biochemistry, it analyzes the three-dimensional structure of biological macromolecules and their complexes, and explains the molecular mechanisms of proteins, nucleic acids, etc. that exert biological functions from the perspective of atoms. Therefore, an in-depth understanding of the three-dimensional structure of proteins is not only conducive to people's in-depth understanding of protein biological functions, but also provides a theoretical basis for genetic improvement and rational distribution of rice disease-resistant varieties, drug design, vaccine development and other application fields. X-ray crystallography is recognized as the most reliable method for analyzing the three-dimensional structure of proteins. However, on the one hand, this technology has strict requirements on protein purity (95%-99%), stability, biological activity, etc.; on the other hand, the bottleneck is the crystallization method. Therefore, obtaining high-quality protein samples and stable and reproducible high-quality crystals is of great significance for advancing structural biology to analyze protein-protein, protein-nucleic acid and other biomacromolecular interaction mechanisms.
水稻和稻瘟病菌是植物与病原物相互作用的主要研究模式体系之一。目前已克隆水稻R基因25个和稻瘟病菌无毒基因11个,二者相互作用符合典型的“基因对基因假说”(Flor,1971)。已有研究表明,水稻中单个R基因不足以抵御病原菌的入侵,需要依赖成对的R基因共同参与防卫反应。水稻抗病基因Pia由两个R基因组成,RGA4和RGA5,翻译形成CC-NBS-LRR蛋白;在寄主体内可形成同源和异源复合物(Cesari et al.,2014;Cesari etal.,2013;de Guillen et al.,2015)。当RGA4单独存在的条件下,自发诱发寄主产生细胞过敏性坏死反应,该激活活性受到RGA5 的抑制。进一步分析发现,在RGA5蛋白C末端存在一个不保守的非LRR结构域(RGA5A_S结构域,包含金属离子结合结构域RATX1),直接参与识别两个序列不一致的效应因子AVR1-CO39、AVR-Pia。RGA5RATX1是参与病原菌识别的核心结合结构域,通过与AVR1-CO39、AVR-Pia直接结合,解除对RGA4的抑制,从而引发效应因子诱导的抗病反应(Cesari et al.,2014;Cesari et al.,2013)。RGA5还存在其他结构域直接参与效应因子AVR-Pia的识别,调节寄主免疫反应(Ortiz et al., 2017)。AVR1-CO39激发Pia水稻植株产生的活性氧爆发先天免疫反应,不仅能控制稻瘟病菌(M.oryzae)的入侵,还能够抑制革兰氏阳性细菌Xanthomonas oryzae pv. oryzae(Xoo)和Xanthomonas oryzaepv.oryzicola(Xoc)引起的水稻白叶枯病和水稻细菌性条斑病(Hutin et al.,2016)。目前,RGA5A_S识别稻瘟病菌效应因子 AVR1-CO39的互作机制尚不清楚,有待进一步研究。因此,需要针对水稻受体蛋白 Pia RGA5A_S提供一种晶体制备和生长技术,为深入了解植物受体R蛋白识别真菌效应因子提供结构基础。Rice and Magnaporthe grisea are one of the main model systems for the study of plant-pathogen interactions. So far, 25 rice R genes and 11 rice blast fungus avirulence genes have been cloned, and the interaction between the two conforms to the typical "gene-to-gene hypothesis" (Flor, 1971). Studies have shown that a single R gene in rice is not enough to resist the invasion of pathogenic bacteria, and it needs to rely on paired R genes to participate in the defense response. The rice disease resistance gene Pia consists of two R genes, RGA4 and RGA5, which translate to form the CC-NBS-LRR protein; homologous and heterologous complexes can be formed in the host (Cesari et al., 2014; Cesari et al., 2013 ; de Guillen et al., 2015). When RGA4 exists alone, it can spontaneously induce the host to produce allergic necrosis, and this activation activity is inhibited by RGA5. Further analysis found that there is a non-conserved non-LRR domain (RGA5A_S domain, including the metal ion binding domain RATX1) at the C-terminus of RGA5 protein, which is directly involved in the recognition of two sequence-discordant effectors AVR1-CO39 and AVR-Pia. RGA5RATX1 is the core binding domain involved in the recognition of pathogenic bacteria. It releases the inhibition of RGA4 by directly binding to AVR1-CO39 and AVR-Pia, thereby triggering the disease resistance induced by effectors (Cesari et al., 2014; Cesari et al. , 2013). There are other domains in RGA5 that are directly involved in the recognition of the effector AVR-Pia, which regulates the host immune response (Ortiz et al., 2017). AVR1-CO39 stimulated the ROS burst innate immune response produced by Pia rice plants, which not only controlled the invasion of rice blast fungus (M. oryzae), but also inhibited the Gram-positive bacteria Xanthomonas oryzae pv. oryzae (Xoo) and Xanthomonas oryzaepv. rice bacterial blight and rice bacterial streak caused by oryzicola (Xoc) (Hutin et al., 2016). At present, the interaction mechanism of RGA5A_S recognizing the rice blast fungus effector AVR1-CO39 is not clear and needs further study. Therefore, it is necessary to provide a crystal preparation and growth technique for the rice receptor protein Pia RGA5A_S to provide a structural basis for in-depth understanding of the plant receptor R protein's recognition of fungal effectors.
前期研究发现,水稻受体蛋白RGA5A_S蛋白存在对温度敏感、易沉淀等问题。采用现有的蛋白质结晶方法,容易造成晶体生长机械手管道堵塞、蛋白质严重沉淀、晶体质量低等问题。Previous studies have found that the rice receptor protein RGA5A_S protein has problems such as temperature sensitivity and easy precipitation. Using the existing protein crystallization method, it is easy to cause problems such as blockage of the crystal growth manipulator pipeline, serious protein precipitation, and low crystal quality.
发明内容Contents of the invention
本发明针对RGA5A_S蛋白对温度敏感,浓缩时易沉淀,结晶效率差以及晶体衍射质量低等问题,提供水稻受体蛋白RGA5A_S的制备及结晶方法。Aiming at the problems that the RGA5A_S protein is sensitive to temperature, easy to precipitate when concentrated, poor crystallization efficiency and low crystal diffraction quality, the invention provides a preparation and crystallization method of the rice receptor protein RGA5A_S.
为了实现本发明目的,本发明提供一种水稻受体蛋白RGA5A_S的制备方法,其是利用原核表达系统表达水稻受体蛋白RGA5A_S,经过菌体裂解,裂解上清液依次过亲和层析柱、分子筛层析柱,最终得到纯化的目的蛋白。其中,重组菌诱导摇培时培养基中添加有100μM Zn2+(ZnCl2)。In order to realize the object of the present invention, the present invention provides a kind of preparation method of rice receptor protein RGA5A_S, and it is to utilize prokaryotic expression system to express rice receptor protein RGA5A_S, through thalline lysing, cleavage supernatant passes through affinity chromatography column successively, Molecular sieve chromatography column to finally obtain the purified target protein. Wherein, 100 μM Zn 2+ (ZnCl 2 ) was added to the culture medium when the recombinant bacteria were induced and shaken.
前述的方法,所述重组菌是将携带有水稻受体蛋白RGA5A_S编码基因的表达载体转化到大肠杆菌中构建得到的。In the aforementioned method, the recombinant bacterium is constructed by transforming the expression vector carrying the gene encoding the rice receptor protein RGA5A_S into Escherichia coli.
本发明蛋白RGA5A_S的氨基酸序列如SEQ ID NO:2所示。优选地,所述水稻受体蛋白RGA5A_S编码基因的序列如SEQ ID NO:1所示。The amino acid sequence of the protein RGA5A_S of the present invention is shown in SEQ ID NO:2. Preferably, the sequence of the gene encoding the rice receptor protein RGA5A_S is shown in SEQ ID NO:1.
优选地,所述表达载体为pETM13。所述大肠杆菌为E.coli BL21(DE3)。Preferably, the expression vector is pETM13. The Escherichia coli is E.coli BL21(DE3).
具体地,本发明水稻受体蛋白RGA5A_S的制备方法包括以下步骤:Specifically, the preparation method of the rice receptor protein RGA5A_S of the present invention comprises the following steps:
(1)重组菌诱导表达:重组菌在37℃、220rpm摇培至菌液OD600值0.6~0.8,添加终浓度为100μM ZnCl2和0.1mM IPTG,18℃、180rpm诱导16~18h;(1) Induced expression of recombinant bacteria: Shaking culture of recombinant bacteria at 37°C and 220 rpm until the OD 600 value of the bacterial solution is 0.6-0.8, adding a final concentration of 100 μM ZnCl 2 and 0.1 mM IPTG, and inducing at 18°C and 180 rpm for 16-18 hours;
(2)菌体裂解:收集经IPTG诱导的菌液,室温6000rpm离心8min,弃上清,收集菌体;用裂解缓冲液(20mM PBS,pH 7.0,500mM NaCl)重悬菌体;超声裂解,开2s,关4s,功率400-600W,10min;2个循环;裂解物经12 000-13 000rpm,4℃离心25-30min,得到细胞裂解上清液;(2) Phytolysis: collect the bacterium liquid induced by IPTG, centrifuge at 6000rpm at room temperature for 8min, discard the supernatant, and collect the bacterium; resuspend the bacterium with lysis buffer (20mM PBS, pH 7.0, 500mM NaCl); ultrasonically lyse, Turn on for 2s, turn off for 4s, power 400-600W, 10min; 2 cycles; the lysate is centrifuged at 12 000-13 000rpm, 4°C for 25-30min to obtain the cell lysate supernatant;
(3)亲和层析:将100mL细胞裂解上清液均分3份,分别加至3个经200 mM ZnCl2预处理的亲和层析柱(chelating fast flow agarose column)上;穿出液重新挂柱一次;然后用含不同浓度咪唑0、20、60、500mM的洗脱缓冲液进行梯度洗脱;(3) Affinity chromatography: 100mL cell lysate supernatant was divided into 3 parts, respectively added to 3 affinity chromatography columns pretreated with 200 mM ZnCl 2 (chelating fast flow agarose column); the penetrating solution was re-hanged on the column once; then gradient elution was performed with elution buffers containing different concentrations of imidazole 0, 20, 60, and 500 mM;
(4)分子筛层析:分别收集60、500mM咪唑洗脱液,添加终浓度为4mM的 DTT(二硫苏糖醇),分别浓缩至1mL;然后加样至75 10/300GL凝胶柱上,用层析缓冲液进行洗脱,合并收集的穿出液,穿出液中含有纯化的目的蛋白。(4) Molecular sieve chromatography: collect 60 and 500 mM imidazole eluents respectively, add DTT (dithiothreitol) with a final concentration of 4 mM, and concentrate to 1 mL respectively; then add samples to 75 10/300GL gel column, eluted with chromatography buffer, and combined the collected flow-through, which contained the purified target protein.
优选地,本发明所用亲和层析柱为chelating fast flow agarosecolumn。Preferably, the affinity chromatography column used in the present invention is chelating fast flow agarose column.
步骤(3)所用洗脱缓冲液的基料为:20mM PBS,pH 7.0,500mM NaCl。The base material of the elution buffer used in step (3) is: 20 mM PBS, pH 7.0, 500 mM NaCl.
其中,咪唑浓度为0、20、60、500mM的洗脱缓冲液对应的洗脱体积为40、10、 10、10mL。Wherein, the elution volumes corresponding to the elution buffers with imidazole concentrations of 0, 20, 60, and 500 mM are 40, 10, 10, and 10 mL.
步骤(4)所用层析缓冲液的配方为:20mM Tris-HCl,pH 8.0,150mM NaCl,5mM DTT和4mM EDTA。The formula of the chromatography buffer used in step (4) is: 20mM Tris-HCl, pH 8.0, 150mM NaCl, 5mM DTT and 4mM EDTA.
上述步骤(2)~(4)应尽量在冰上或4℃条件下进行。The above steps (2)-(4) should be carried out on ice or at 4°C as much as possible.
本发明还提供水稻受体蛋白RGA5A_S的结晶方法,用缓冲液将上述方法制备的目的蛋白配制成浓度6.4mg/mL的蛋白溶液,然后在0.2M NH4NO3和20% PEG3350(v/v)存在的条件下,于16℃恒温培养箱中静置培养3-5天,获得微量晶体;然后以其为晶种,在0.18-0.22M NH4NO3和18%-22%PEG3350(v/v)存在的条件下,于16℃恒温培养箱中静置培养3-5天,得到水稻受体蛋白RGA5A_S 的单晶。The present invention also provides the crystallization method of rice receptor protein RGA5A_S, the target protein prepared by the above method is prepared into a protein solution with a concentration of 6.4 mg/mL with a buffer, and then mixed in 0.2M NH 4 NO 3 and 20% PEG3350 (v/v ) in the presence of 16 °C in a constant temperature incubator for 3-5 days to obtain a small amount of crystals; In the presence of /v), the single crystal of the rice receptor protein RGA5A_S is obtained by statically culturing in a constant temperature incubator at 16° C. for 3-5 days.
优选地,晶种在0.18M NH4NO3和20%PEG3350存在的条件下静置培养,获得单晶。Preferably, the seed crystals are statically cultured in the presence of 0.18M NH 4 NO 3 and 20% PEG3350 to obtain single crystals.
其中,所述缓冲液的配方为:20mM PBS,pH 7.0,150mM NaCl,5mM DTT 和4mMEDTA。Wherein, the formula of the buffer solution is: 20mM PBS, pH 7.0, 150mM NaCl, 5mM DTT and 4mM EDTA.
借由上述技术方案,本发明至少具有下列优点及有益效果:By virtue of the above technical solutions, the present invention has at least the following advantages and beneficial effects:
(一)针对目的蛋白RGA5A_S包含金属离子结构域(具有MxCxxS基序,x 表示任意氨基酸)的特点,在重组菌摇培时向培养基中添加了Zn2+,对稳定蛋白的状态具有重要作用。(1) In view of the characteristic that the target protein RGA5A_S contains a metal ion domain (with MxCxxS motif, x represents any amino acid), Zn 2+ was added to the culture medium during shaking culture of the recombinant bacteria, which played an important role in stabilizing the state of the protein .
(二)采用鸟枪法和九宫格法对蛋白结晶条件进行筛选和优化,结果发现,蛋白RGA5A_S在0.18M NH4NO3和20%PEG3350条件下可获得大量单晶,所得晶体大、质量好、分辨率高,且该方法重复性好。(2) Shotgun method and Jiugongge method were used to screen and optimize protein crystallization conditions. It was found that protein RGA5A_S can obtain a large number of single crystals under the conditions of 0.18M NH 4 NO 3 and 20% PEG3350. The rate is high, and the method has good repeatability.
(三)由于蛋白RGA5A_S(不含有6×His标签),靠非保守的金属离子结合基序MxCxxS与Zn2+柱结合,结合力较6×His-tag差,因此,本发明选用含不同浓度咪唑的洗脱缓冲液对挂柱目的蛋白进行梯度洗脱,以保证低浓度下去除杂蛋白,高浓度下将高纯度目的蛋白完全洗脱。(3) Since the protein RGA5A_S (does not contain 6×His tag), relies on the non-conserved metal ion binding motif MxCxxS to bind to the Zn 2+ column, and its binding force is worse than that of 6×His-tag. Therefore, the present invention uses The elution buffer of imidazole performs gradient elution on the target protein on the column to ensure that the impurity protein is removed at low concentration, and the high-purity target protein is completely eluted at high concentration.
附图说明Description of drawings
图1为本发明实施例2中获得的水稻受体蛋白RGA5A_S的微小晶体的偏光显微镜照片。Fig. 1 is a polarizing microscope photo of the tiny crystals of the rice receptor protein RGA5A_S obtained in Example 2 of the present invention.
图2为本发明实施例2中获得的水稻受体蛋白RGA5A_S的单晶的偏光显微镜照片。Fig. 2 is a polarized light microscope photo of a single crystal of the rice receptor protein RGA5A_S obtained in Example 2 of the present invention.
图3为本发明实施例2中水稻受体蛋白RGA5A_S晶体的的X-射线衍射数据。Fig. 3 is the X-ray diffraction data of the rice receptor protein RGA5A_S crystal in Example 2 of the present invention.
具体实施方式Detailed ways
以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别指明,实施例均按照常规实验条件,如Sambrook等分子克隆实验手册(Sambrook J&Russell DW,Molecular Cloning:a Laboratory Manual,2001),或按照制造厂商说明书建议的条件。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the examples are all in accordance with conventional experimental conditions, such as Sambrook et al. Molecular Cloning Experiment Manual (Sambrook J & Russell DW, Molecular Cloning: a Laboratory Manual, 2001), or in accordance with the conditions suggested by the manufacturer's instructions.
实施例1水稻受体蛋白RGA5A_S的制备The preparation of embodiment 1 rice receptor protein RGA5A_S
1、重组表达载体的构建1. Construction of recombinant expression vector
(1)引物设计(1) Primer design
从NCBI上获得RGA5_RATX1(GenBank:BAK39930.1)目的序列,经密码子优化后合成基因序列。利用Sticky-end方法设计引物,根据选用载体的限制性酶切位点和目的序列限制性内切酶分析,选择限制性内切酶(NcoI/XhoI),利用DNAMAN 8.0设计两组引物。The target sequence of RGA5_RATX1 (GenBank: BAK39930.1) was obtained from NCBI, and the gene sequence was synthesized after codon optimization. Primers were designed using the Sticky-end method, and restriction enzymes (NcoI/XhoI) were selected according to the restriction enzyme sites of the selected vector and the restriction enzyme analysis of the target sequence, and two sets of primers were designed using DNAMAN 8.0.
F1-NcoI:catg CTGTCTAACA TGGAATCTGTF1-NcoI: catg CTGTCTAACA TGGAATCTGT
R1-XhoI:g CATAGTGCTG CACGGGTTR1-XhoI:g CATAGTGCTG CACGGGTT
F2-NcoI:CTGTCTAACA TGGAATCTGT AGTAGF2-NcoI: CTGTCTAACA TGGAATCTGT AGTAG
R2-XhoI:tcgag CATAGTGCTG CACGGGTR2-XhoI: tcgag CATAGTGCTG CACGGGT
(2)PCR扩增目的片段和产物回收(2) PCR amplification target fragment and product recovery
采用Sticky-end的方法(Pham et al.,1998),将PCR扩增产物通过退火产生与载体末端互补的粘性末端。Using the Sticky-end method (Pham et al., 1998), the PCR amplification product was annealed to generate a sticky end complementary to the end of the vector.
(3)变复性-退火产生粘末端(3) Denaturation-annealing produces sticky ends
利用NaNo Drop K550微量分光光度计检测PCR纯化产物浓度,按照摩尔比 1:1混合。利用PCR仪进行变复性,获得末端突出的双链DNA。Use a NaNo Drop K550 micro-spectrophotometer to detect the concentration of PCR purified products, and mix them according to the molar ratio of 1:1. Denaturation and renaturation were performed using a PCR instrument to obtain double-stranded DNA with overhanging ends.
变性、复性条件:94℃变性5min,65℃变性15min,16℃冷却。Denaturation and renaturation conditions: Denaturation at 94°C for 5 minutes, denaturation at 65°C for 15 minutes, cooling at 16°C.
(4)酶切表达载体pETM13(4) Enzyme cutting expression vector pETM13
对目的片段进行酶切,对载体进行双酶切,37℃孵育4-5h,Carry out enzyme digestion to the target fragment, double enzyme digestion to the vector, incubate at 37°C for 4-5h,
(5)载体与目的片段连接(5) The vector is connected to the target fragment
在T4DNA连接酶的作用下,将变复性后产生粘性末端的PCR产物连接到酶切后具有相同末端的载体上,16℃孵育过夜。Under the action of T4 DNA ligase, the PCR product with cohesive ends after renaturation was ligated to the carrier with the same ends after digestion, and incubated overnight at 16°C.
(6)热击转化与抗性筛选(6) Heat shock transformation and resistance screening
-80℃冰箱取出感受态细胞E.coli JM109/DH5α,至于冰上溶解;Take out the competent cells E.coli JM109/DH5α from the refrigerator at -80°C, and dissolve them on ice;
向连接产物中加入50μL感受态细胞,冰上静置30min;Add 50 μL of competent cells to the ligation product, and let stand on ice for 30 minutes;
42℃水浴热击90s,立即于冰上静置2min;Shock in a water bath at 42°C for 90 seconds, and immediately place it on ice for 2 minutes;
超净台内加入500μL SOC培养基,37℃、220rpm振荡培养40min;Add 500 μL of SOC medium into the ultra-clean bench, shake and incubate at 37°C, 220rpm for 40min;
将培养基均匀涂至含有与载体相同抗性的LB平板,风干(超净台内操作);Apply the culture medium evenly to the LB plate containing the same resistance as the carrier, and air-dry (operate in the ultra-clean bench);
倒置于37℃恒温培养箱过夜生长。Inverted in a 37°C constant temperature incubator to grow overnight.
(7)重组子验证(7) Recombinant verification
随机挑取单克隆置于1mL相应抗性的LB液体培养基;Randomly pick a single clone and place it in 1 mL of the corresponding resistant LB liquid medium;
37℃、220rpm振荡培养5-10h;37°C, 220rpm shaking culture for 5-10h;
菌液PCR验证插入片段是否正确;Bacterial liquid PCR to verify whether the inserted fragment is correct;
扩增产物经琼脂糖凝胶检测后,选择条带与目的片段(SEQ ID NO:1)大小一致的菌液,送公司测序。利用DNAMAN8.0或NCBI将测序结果于目的序列进行比对,确认重组质粒中目的序列携带的酶切位点一致,碱基间有无移码和无点突变,则说明重组表达载体构建成功,可用于后续实验。After the amplified product was detected by agarose gel, select the bacterial solution with the same size band as the target fragment (SEQ ID NO: 1) and send it to the company for sequencing. Use DNAMAN8.0 or NCBI to compare the sequencing results with the target sequence, and confirm that the restriction site carried by the target sequence in the recombinant plasmid is consistent, and whether there is a frameshift or point mutation between the bases, it means that the recombinant expression vector is successfully constructed. can be used in subsequent experiments.
2、重组菌诱导表达及目的蛋白的分离纯化2. Induced expression of recombinant bacteria and separation and purification of target protein
(1)将上述重组表达载体转化到大肠杆菌E.coli BL21(DE3)中,在37℃、220 rpm摇培至菌液OD600值0.8,添加终浓度为100μM ZnCl2和0.1mM IPTG,18℃、 180rpm诱导18h。(1) Transform the above recombinant expression vector into Escherichia coli E.coli BL21(DE3), shake culture at 37°C and 220 rpm until the OD 600 value of the bacterial solution is 0.8, add the final concentration of 100μM ZnCl 2 and 0.1mM IPTG, 18 ℃, 180rpm induction 18h.
(2)菌体裂解:收集经IPTG诱导的菌液,室温6000rpm离心8min,弃上清,收集菌体;用裂解缓冲液(20mM PBS,pH 7.0,500mM NaCl)重悬菌体;超声裂解,开2s,关4s,功率400-600W,10min;2个循环;裂解物经12 000-13 000rpm,4℃离心25-30min,得到细胞裂解上清液。(2) Phytolysis: collect the bacterium induced by IPTG, centrifuge at 6000rpm at room temperature for 8min, discard the supernatant, and collect the bacterium; resuspend the bacterium with lysis buffer (20mM PBS, pH 7.0, 500mM NaCl); ultrasonically lyse, Turn on for 2s, turn off for 4s, power 400-600W, 10min; 2 cycles; lysate is centrifuged at 12 000-13 000rpm, 4°C for 25-30min to obtain cell lysate supernatant.
(3)亲和层析:将100mL细胞裂解上清液均分3份,分别加至3个经200 mM ZnCl2预处理的亲和层析柱上;穿出液重新挂柱一次;然后用含不同浓度咪唑0、 20、60、500mM的洗脱缓冲液进行梯度洗脱。(3) Affinity chromatography: 100mL cell lysate supernatant was divided into 3 parts, respectively added to 3 affinity chromatography columns pretreated with 200 mM ZnCl 2 ; Gradient elution was performed with elution buffers containing different concentrations of imidazole 0, 20, 60, and 500 mM.
其中,所用亲和层析柱为chelating fast flow agarose column。Among them, the affinity chromatography column used is chelating fast flow agarose column.
所用洗脱缓冲液的基料为:20mM PBS,pH 7.0,500mM NaCl。The base of the elution buffer used was: 20 mM PBS, pH 7.0, 500 mM NaCl.
咪唑浓度为0、20、60、500mM的洗脱缓冲液对应的洗脱体积为40、10、10、 10mL。The elution volumes corresponding to the elution buffers with imidazole concentrations of 0, 20, 60, and 500 mM are 40, 10, 10, and 10 mL.
(4)分子筛层析:分别收集60、500mM咪唑洗脱液,添加终浓度为4mM的DTT,分别浓缩至1mL;然后加样至75 10/300GL凝胶柱上,用层析缓冲液进行洗脱,穿出液中含有纯化的目的蛋白。(4) Molecular sieve chromatography: Collect 60 and 500 mM imidazole eluents respectively, add DTT with a final concentration of 4 mM, and concentrate to 1 mL respectively; then add samples to 75 10/300GL gel column, eluted with chromatography buffer, and the purified target protein was contained in the flow-through solution.
其中,所用层析缓冲液的配方为:20mM Tris-HCl,pH 8.0,150mM NaCl,5mM DTT和4mM EDTA。Wherein, the formula of the chromatographic buffer used is: 20mM Tris-HCl, pH 8.0, 150mM NaCl, 5mM DTT and 4mM EDTA.
实施例2水稻受体蛋白RGA5A_S的结晶方法The crystallization method of embodiment 2 rice receptor protein RGA5A_S
1、鸟枪法筛选蛋白质结晶条件1. Screening conditions for protein crystallization by shotgun method
将实施例1制备的蛋白RGA5A_S溶解于缓冲液(20mM PBS,pH 7.0,150mM NaCl,5mMDTT,4mM EDTA)中,得浓度6.4mg/mL的蛋白溶液。然后进行鸟枪法晶体试剂盒筛选。16℃恒温培养箱中静置培养5天,在JCSG+试剂盒 (Hampton research)C4条件[蛋白溶液中添加有NH4NO3和PEG3350,终浓度分别为0.2M和20(v/v)%]可观察到微小晶体(图1)。而在其它晶体生长试剂条件下,几乎不能够获得晶体。The protein RGA5A_S prepared in Example 1 was dissolved in a buffer solution (20 mM PBS, pH 7.0, 150 mM NaCl, 5 mM MDTT, 4 mM EDTA) to obtain a protein solution with a concentration of 6.4 mg/mL. Shotgun crystal kit screening was then performed. Static culture in a constant temperature incubator at 16°C for 5 days, under the C4 condition of JCSG+ kit (Hampton research) [NH 4 NO 3 and PEG3350 were added to the protein solution, and the final concentrations were 0.2M and 20 (v/v)% respectively] Tiny crystals can be observed (Figure 1). While under other crystal growth reagent conditions, almost no crystals can be obtained.
2、九宫格和接种策略优化晶体生长条件2. Jiugong grid and inoculation strategy to optimize crystal growth conditions
为了获得高质量的衍射晶体,采用九宫格法优化NH4NO3和PEG3350浓度梯度,以步骤1中获得的微晶为晶种进行晶体生长条件优化。结果发现,RGA5A_S在 0.18M NH4NO3和20%PEG3350(v/v)存在条件下可获得大量单晶(图2)。在X- 射线下衍射,即可得到较高分辨率的衍射数据(一般为左右的分辨率)(图3)。最后,利用相关的分析软件对收集衍射数据进行指标化(Index)、强度积分 (Integration)和归一化(Scaling)处理,即可得到该蛋白质的晶体结构。In order to obtain high-quality diffractive crystals, the NH 4 NO 3 and PEG3350 concentration gradients were optimized using the Jiugongge method, and the crystal growth conditions were optimized using the microcrystals obtained in step 1 as seeds. It was found that RGA5A_S can obtain a large number of single crystals in the presence of 0.18M NH 4 NO 3 and 20% PEG3350 (v/v) (Fig. 2). Diffraction under X-rays can obtain higher resolution diffraction data (generally left and right resolution) (Figure 3). Finally, the crystal structure of the protein can be obtained by using relevant analysis software to perform indexing (Index), intensity integration (Integration) and normalization (Scaling) processing on the collected diffraction data.
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之做一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
参考文献references
Cesari,S.,et al.(2014).″A novel conserved mechanism for plant NLRprotein pairs:the“integrated decoy”hypothesis.″Frontiers in plant science 5.Cesari,S.,et al.(2014).″A novel conserved mechanism for plant NLRprotein pairs: the“integrated decoy”hypothesis.” Frontiers in plant science 5.
Cesari,S.,et al.(2013).″The rice resistance protein pair RGA4/RGA5recognizes the Magnaporthe oryzae effectors AVR-Pia and AVR1-CO39bydirect binding.″The Plant Cell 25(4):1463-1481.Cesari, S., et al.(2013). "The rice resistance protein pair RGA4/RGA5 recognizes the Magnaporthe oryzae effectors AVR-Pia and AVR1-CO39 by direct binding." The Plant Cell 25(4):1463-1481.
de Guillen,K.,et al.(2015).″Structure analysis uncovers a highlydiverse but structurally conserved effector family in phytopathogenic fungi.″PLoS pathogens 11(10):e1005228.de Guillen, K., et al.(2015). "Structure analysis uncovers a highly diverse but structurally conserved effector family in phytopathogenic fungi." PLoS pathogens 11(10):e1005228.
Dean,R.,et al.(2012).″The Top 10fungal pathogens in molecular plantpathology.″Molecular plant pathology 13(4): 414-430.Dean, R., et al. (2012). "The Top 10 fungal pathogens in molecular plant pathology." Molecular plant pathology 13(4): 414-430.
Fisher,M.C.,et al.(2012).″Emerging fungal threats to animal,plant andecosystem health.″Nature 484(7393):186-194.Fisher, MC, et al. (2012). "Emerging fungal threats to animal, plant and ecosystem health." Nature 484(7393):186-194.
Flor,H.H.(1971).″Current status of the gene-for-gene concept.″Annual review of phytopathology 9(1):275-296.Flor, HH (1971). "Current status of the gene-for-gene concept." Annual review of phytopathology 9(1):275-296.
Hutin,M.,et al.(2016).″Ectopic activation of the rice NLR heteropairRGA4/RGA5confers resistance to bacterial blight and bacterial leaf streakdiseases.″The Plant Journal 88(1):43-55.Hutin, M., et al.(2016). "Ectopic activation of the rice NLR heteropair RGA4/RGA5 confers resistance to bacterial blight and bacterial leaf streak diseases." The Plant Journal 88(1):43-55.
Liu,W.and G.-L.Wang(2016).″Plant innate immunity in rice:a defenseagainst pathogen infection.″National Science Review 3(3):295-308.Liu, W. and G.-L. Wang(2016). "Plant innate immunity in rice: a defense against pathogen infection." National Science Review 3(3):295-308.
Ortiz,D.,et al.(2017).″Recognition of the Magnaporthe oryzae effectorAVR-Pia by the decoy domain of the rice NLR immune receptor RGA5.″The Plant Cell Online 29(1):156-168.Ortiz, D., et al.(2017). "Recognition of the Magnaporthe oryzae effector AVR-Pia by the decoy domain of the rice NLR immune receptor RGA5." The Plant Cell Online 29(1):156-168.
张璟,et al.(2014).″2030年世界粮食发展及其对中美两国国家战略选择的影响.″世界农业(3):I0001-I0001.Zhang Jing, et al.(2014). "World food development in 2030 and its impact on the national strategic choices of China and the United States." World Agriculture (3): I0001-I0001.
周锡跃,et al.(2010).″世界水稻产业发展现状,趋势及对我国的启示.″農業現 代化研究31(5):525-528。Zhou Xiyue, et al.(2010). "The Development Status, Trend and Enlightenment of China's Rice Industry in the World." Agricultural Modernization Research 31(5):525-528.
序列表sequence listing
<110> 中国农业大学<110> China Agricultural University
<120> 水稻受体蛋白 RGA5A_S 的制备及结晶方法<120> Preparation and Crystallization of Rice Receptor Protein RGA5A_S
<130> KHP181112033.0<130> KHP181112033.0
<160> 2<160> 2
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 405<211> 405
<212> DNA<212>DNA
<213> 水稻(Oryza sativa)<213> Rice (Oryza sativa)
<400> 1<400> 1
ctgtctaaca tggaatctgt agtagagtct gcgctgaccg gccagcgtac taagatcgtg 60ctgtctaaca tggaatctgt agtagagtct gcgctgaccg gccagcgtac taagatcgtg 60
gttaaggtac acatgccgtg tggcaaaagc cgcgctaaag ctatggcgct ggcagcaagc 120gttaaggtac acatgccgtg tggcaaaagc cgcgctaaag ctatggcgct ggcagcaagc 120
gtgaacggtg tggactctgt agaaattacc ggcgaagaca aagatcgcct ggtagttgta 180gtgaacggtg tggactctgt agaaattacc ggcgaagaca aagatcgcct ggtagttgta 180
ggccgtggca tcgatccggt tcgtctggtg gcgctgctgc gtgaaaaatg cggcctggcg 240ggccgtggca tcgatccggt tcgtctggtg gcgctgctgc gtgaaaaatg cggcctggcg 240
gaactgctga tggtagaact ggttgaaaaa gaaaagaccc agctggctgg cggcaaaaag 300gaactgctga tggtagaact ggttgaaaaa gaaaagaccc agctggctgg cggcaaaaag 300
ggcgcgtaca agaaacaccc gacctacaac ctgagcccgt tcgattacgt tgaatacccg 360ggcgcgtaca agaaacaccc gacctacaac ctgagcccgt tcgattacgt tgaatacccg 360
ccgtccgctc cgattatgca ggacattaac ccgtgcagca ctatg 405ccgtccgctc cgattatgca ggacattaac ccgtgcagca ctatg 405
<210> 2<210> 2
<211> 135<211> 135
<212> PRT<212> PRT
<213> 水稻(Oryza sativa)<213> Rice (Oryza sativa)
<400> 2<400> 2
Leu Ser Asn Met Glu Ser Val Val Glu Ser Ala Leu Thr Gly Gln ArgLeu Ser Asn Met Glu Ser Val Val Glu Ser Ala Leu Thr Gly Gln Arg
1 5 10 151 5 10 15
Thr Lys Ile Val Val Lys Val His Met Pro Cys Gly Lys Ser Arg AlaThr Lys Ile Val Val Lys Val His Met Pro Cys Gly Lys Ser Arg Ala
20 25 30 20 25 30
Lys Ala Met Ala Leu Ala Ala Ser Val Asn Gly Val Asp Ser Val GluLys Ala Met Ala Leu Ala Ala Ser Val Asn Gly Val Asp Ser Val Glu
35 40 45 35 40 45
Ile Thr Gly Glu Asp Lys Asp Arg Leu Val Val Val Gly Arg Gly IleIle Thr Gly Glu Asp Lys Asp Arg Leu Val Val Val Gly Arg Gly Ile
50 55 60 50 55 60
Asp Pro Val Arg Leu Val Ala Leu Leu Arg Glu Lys Cys Gly Leu AlaAsp Pro Val Arg Leu Val Ala Leu Leu Arg Glu Lys Cys Gly Leu Ala
65 70 75 8065 70 75 80
Glu Leu Leu Met Val Glu Leu Val Glu Lys Glu Lys Thr Gln Leu AlaGlu Leu Leu Met Val Glu Leu Val Glu Lys Glu Lys Thr Gln Leu Ala
85 90 95 85 90 95
Gly Gly Lys Lys Gly Ala Tyr Lys Lys His Pro Thr Tyr Asn Leu SerGly Gly Lys Lys Gly Ala Tyr Lys Lys His Pro Thr Tyr Asn Leu Ser
100 105 110 100 105 110
Pro Phe Asp Tyr Val Glu Tyr Pro Pro Ser Ala Pro Ile Met Gln AspPro Phe Asp Tyr Val Glu Tyr Pro Pro Ser Ala Pro Ile Met Gln Asp
115 120 125 115 120 125
Ile Asn Pro Cys Ser Thr MetIle Asn Pro Cys Ser Thr Met
130 135 130 135
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810475252.8A CN110498847B (en) | 2018-05-17 | 2018-05-17 | Preparation and crystallization method of rice receptor protein RGA5A _ S |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810475252.8A CN110498847B (en) | 2018-05-17 | 2018-05-17 | Preparation and crystallization method of rice receptor protein RGA5A _ S |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110498847A true CN110498847A (en) | 2019-11-26 |
CN110498847B CN110498847B (en) | 2021-06-22 |
Family
ID=68585091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810475252.8A Expired - Fee Related CN110498847B (en) | 2018-05-17 | 2018-05-17 | Preparation and crystallization method of rice receptor protein RGA5A _ S |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110498847B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110922462A (en) * | 2019-12-20 | 2020-03-27 | 中国农业大学 | An artificially modified rice disease resistance gene RGA5-HMA2 |
CN110922463A (en) * | 2019-12-20 | 2020-03-27 | 中国农业大学 | Rice disease-resistant gene RGA5-HMA5 and application thereof in rice breeding |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101240282A (en) * | 2007-02-09 | 2008-08-13 | 福建农林大学 | Avirulent Gene Avr-Pib of Magnaporthe grisea and Its Application |
CN104356213A (en) * | 2014-10-23 | 2015-02-18 | 华南农业大学 | Magnaporthe oryzae avirulence gene AvrPib and application thereof |
-
2018
- 2018-05-17 CN CN201810475252.8A patent/CN110498847B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101240282A (en) * | 2007-02-09 | 2008-08-13 | 福建农林大学 | Avirulent Gene Avr-Pib of Magnaporthe grisea and Its Application |
CN104356213A (en) * | 2014-10-23 | 2015-02-18 | 华南农业大学 | Magnaporthe oryzae avirulence gene AvrPib and application thereof |
Non-Patent Citations (5)
Title |
---|
A MAQBOOL等: "Structural basis of pathogen recognition by an integrated HMA domain in a plant NLR immune receptor", 《ELIFE》 * |
GUO LIWEI等: "Crystallization of the rice immune receptor RGA5A_S with the rice blast fungus effector AVR1-CO39 prepared via mixture and tandem strategies", 《ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS》 * |
HUANG DAN等: "Expression, purification, crystallization and preliminary X-ray diffraction analysis of the effector-interaction domain of the resistance protein RGA5-A from Oryza sativa L. japonica", 《ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS》 * |
STELLA CESARI等: "The rice resistance protein pair RGA4/RGA5 recognizes the Magnaporthe oryzae effectors AVR-Pia and AVR1-CO39 by direct binding", 《PLANT CELL》 * |
杨铭: "《结构生物学概论》", 31 July 2002, 北京医科大学出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110922462A (en) * | 2019-12-20 | 2020-03-27 | 中国农业大学 | An artificially modified rice disease resistance gene RGA5-HMA2 |
CN110922463A (en) * | 2019-12-20 | 2020-03-27 | 中国农业大学 | Rice disease-resistant gene RGA5-HMA5 and application thereof in rice breeding |
CN110922463B (en) * | 2019-12-20 | 2021-05-11 | 中国农业大学 | Rice disease resistance gene RGA5-HMA5 and its application in rice breeding |
CN110922462B (en) * | 2019-12-20 | 2021-05-11 | 中国农业大学 | An artificially modified rice disease resistance gene RGA5-HMA2 |
Also Published As
Publication number | Publication date |
---|---|
CN110498847B (en) | 2021-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Maqbool et al. | Structural basis of pathogen recognition by an integrated HMA domain in a plant NLR immune receptor | |
Udawat et al. | Heterologous expression of an uncharacterized universal stress protein gene (SbUSP) from the extreme halophyte, Salicornia brachiata, which confers salt and osmotic tolerance to E. coli | |
Hur et al. | Molecular cloning and characterization of OsUPS, a U-box containing E3 ligase gene that respond to phosphate starvation in rice (Oryza sativa) | |
Hou et al. | A SBP-Box gene VpSBP5 from Chinese wild vitis species responds to erysiphe necator and defense signaling molecules | |
CN110498847A (en) | Preparation and crystallization method of rice receptor protein RGA5A_S | |
Neshani et al. | Preparation and evaluation of a new biopesticide solution candidate for plant disease control using pexiganan gene and Pichia pastoris expression system | |
Du et al. | Prokaryotic expression, purification, physicochemical properties and antifungal activity analysis of phloem protein PP2-A1 from cucumber | |
Dzurová et al. | The three‐dimensional structure of “Lonely Guy” from C laviceps purpurea provides insights into the phosphoribohydrolase function of R ossmann fold‐containing lysine decarboxylase‐like proteins | |
CN110028561B (en) | A kind of antibacterial protein and its encoding gene and separation and purification method | |
Jia et al. | Structure, function, and applications of soybean calcium transporters | |
Li et al. | The expression, purification and crystallization of a ubiquitin-conjugating enzyme E2 from Agrocybe aegerita underscore the impact of His-tag location on recombinant protein properties | |
Gallerano et al. | Biophysical characterization of recombinant HIV-1 subtype C virus infectivity factor | |
CN102061303A (en) | Fusion expression product of antimicrobial peptide genes of two marine animals and preparation method of fusion expression product | |
Sudom et al. | Mechanisms of activation of phosphoenolpyruvate carboxykinase from Escherichia coli by Ca2+ and of desensitization by trypsin | |
CN112921019B (en) | chitin deacetylase protein crystal | |
CN103275214A (en) | Gene engineering preparation and identification method for shrimp serine protease inhibitor | |
McLuskey et al. | Purification, characterization, and crystallization of Trypanosoma metacaspases | |
Liu et al. | Molecular cloning and expression of AmCDPK from mangrove Avicennia marina under elevated temperature | |
Pereira et al. | A simple strategy for the purification of native recombinant full-length human RPL10 protein from inclusion bodies | |
Gookin et al. | Influence of expression and purification protocols on Gα biochemical activity: kinetics of plant and mammalian G protein cycles | |
Chung et al. | Legionella effector LegA15/AnkH contains an unrecognized cysteine protease-like domain and displays structural similarity to LegA3/AnkD, but differs in host cell localization | |
Chen et al. | Structural insights into DNA sequence recognition by Arabidopsis ETHYLENE RESPONSE FACTOR 96 | |
CN110923289A (en) | A screening method for a drug for the treatment of citrus Huanglongbing | |
CN113337537B (en) | OsCDKB1;1 protein and function and application of encoding gene thereof in salt tolerance of rice | |
CN105296522B (en) | Bt protein expression systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210622 |